fasudil has been researched along with Chronic Kidney Failure in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Fasudil can restrain EMT induced by PTH; this conclusion provides experimental data for the application of fasudil in the clinical prevention and treatment of renal fibrosis." | 3.85 | The influence of fasudil on renal proximal tubular cell epithelial-mesenchymal transition induced by parathormone. ( Cui, T; Gao, Z; Li, Z; Zhang, H; Zhu, W, 2017) |
| "The fasudil treatment resulted in a significant effect in decreasing TF and PAI-1 [p < 0." | 1.43 | Fasudil inhibits tissue factor and plasminogen activator Inhibitor-1 secretion by peripheral blood mononuclear cells in CAPD patients. ( Chen, W; Fu, K; Han, H; Huang, H; Huang, Y; Li, W; Su, H; Su, Y; Wei, J; Wu, W; Xie, M; Xu, W; Yang, X; Zhang, D; Zhang, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z | 1 |
| Zhu, W | 1 |
| Zhang, H | 1 |
| Li, Z | 1 |
| Cui, T | 1 |
| Li, W | 1 |
| Chen, W | 1 |
| Xie, M | 1 |
| Huang, H | 1 |
| Su, H | 1 |
| Han, H | 1 |
| Zhang, D | 1 |
| Zhang, Y | 1 |
| Yang, X | 1 |
| Xu, W | 1 |
| Su, Y | 1 |
| Wu, W | 1 |
| Huang, Y | 1 |
| Fu, K | 1 |
| Wei, J | 1 |
2 other studies available for fasudil and Chronic Kidney Failure
| Article | Year |
|---|---|
The influence of fasudil on renal proximal tubular cell epithelial-mesenchymal transition induced by parathormone.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Antigens, CD; Cadherins; Cell Line; Disease P | 2017 |
Fasudil inhibits tissue factor and plasminogen activator Inhibitor-1 secretion by peripheral blood mononuclear cells in CAPD patients.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Aged; Enzyme-Linked Immunosorbent Assay; Femal | 2016 |